Elise M Weerts1, Gary S Wand1,2, Brion Maher1,3, Xiaoqiang Xu1, Mary Ann Stephens1, Xiaoju Yang2, Mary E McCaul1. 1. Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland. 3. Department of Mental Health, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Abstract
BACKGROUND: The current study examined independent and interactive effects of polymorphisms of the mu opioid receptor gene (OPRM1, A118G) and variable number tandem repeats of the dopamine transporter gene (DAT1, SLC6A3) on alcohol consumption and subjective responses to alcohol in 127 young, healthy, social drinkers. METHODS: Participants completed an in-person assessment, which included self-reported alcohol drinking patterns and blood sampling for DNA, and in a second visit, a cumulative alcohol dosing procedure with subjective ratings across multiple time points and breath alcohol contents (0.03 to 0.1%). DNA was analyzed for OPRM1 AA versus AG/GG (*G) genotypes, DAT1 10-repeat allele (A10) versus 9 or lesser alleles (A9), and ancestral informative markers. RESULTS: There were significant epistatic interactions between OPRM1 and DAT1 genotypes. Subjective High Assessment Scale scores after alcohol consumption were highest in *G and A9 carriers, and lowest in *G and A10 carriers. Negative subjective effects were also highest in *G and A9 carriers. Effects were similar in a sensitivity analysis limited to Caucasian subjects. There were independent and epistatic interactions on drinking. The OPRM1 *G allele was independently associated with fewer heavy drinking days. The A9 allele was associated with a greater number of drinking days, which was attenuated in carriers of the *G allele. CONCLUSIONS: These findings highlight the biological importance of interactions between these 2 genes and interactions between brain opioid and dopamine systems.
BACKGROUND: The current study examined independent and interactive effects of polymorphisms of the mu opioid receptor gene (OPRM1, A118G) and variable number tandem repeats of the dopamine transporter gene (DAT1, SLC6A3) on alcohol consumption and subjective responses to alcohol in 127 young, healthy, social drinkers. METHODS:Participants completed an in-person assessment, which included self-reported alcohol drinking patterns and blood sampling for DNA, and in a second visit, a cumulative alcohol dosing procedure with subjective ratings across multiple time points and breath alcohol contents (0.03 to 0.1%). DNA was analyzed for OPRM1 AA versus AG/GG (*G) genotypes, DAT1 10-repeat allele (A10) versus 9 or lesser alleles (A9), and ancestral informative markers. RESULTS: There were significant epistatic interactions between OPRM1 and DAT1 genotypes. Subjective High Assessment Scale scores after alcohol consumption were highest in *G and A9 carriers, and lowest in *G and A10 carriers. Negative subjective effects were also highest in *G and A9 carriers. Effects were similar in a sensitivity analysis limited to Caucasian subjects. There were independent and epistatic interactions on drinking. The OPRM1 *G allele was independently associated with fewer heavy drinking days. The A9 allele was associated with a greater number of drinking days, which was attenuated in carriers of the *G allele. CONCLUSIONS: These findings highlight the biological importance of interactions between these 2 genes and interactions between brain opioid and dopamine systems.
Authors: Kora-Mareen Bühler; Elena Giné; Victor Echeverry-Alzate; Javier Calleja-Conde; Fernando Rodriguez de Fonseca; Jose Antonio López-Moreno Journal: Addict Biol Date: 2015-01-21 Impact factor: 4.280
Authors: Marta Peciña; Tiffany Love; Christian S Stohler; David Goldman; Jon-Kar Zubieta Journal: Neuropsychopharmacology Date: 2014-10-13 Impact factor: 7.853
Authors: C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu Journal: Proc Natl Acad Sci U S A Date: 1998-08-04 Impact factor: 11.205
Authors: M E Sloan; T D Klepp; J L Gowin; J E Swan; H Sun; B L Stangl; V A Ramchandani Journal: Neuropsychopharmacology Date: 2018-02-02 Impact factor: 7.853
Authors: Raymond F Anton; Konstantin E Voronin; Sarah W Book; Patricia K Latham; Patrick K Randall; Willam Bailey Glen; Michaela Hoffman; Joseph P Schacht Journal: Alcohol Clin Exp Res Date: 2020-09-19 Impact factor: 3.455
Authors: C Austin Zamarripa; Matthew D Novak; Elise M Weerts; Ryan Vandrey; Tory R Spindle Journal: Front Pharmacol Date: 2022-09-06 Impact factor: 5.988